Cargando…
Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis
PURPOSE OF REVIEW: We reviewed the contemporary literature and clinical trials to discuss the applications of the interleukin-1 (IL-1) inhibitor rilonacept to treat pericarditis, with regards to pathophysiology, pharmacology, efficacy, and safety. RECENT FINDINGS: Rilonacept is an emerging novel age...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735734/ https://www.ncbi.nlm.nih.gov/pubmed/34993745 http://dx.doi.org/10.1007/s11886-021-01621-0 |